Spineway

Spineway Capital Expenditures

The Capital Expenditures (CapEx) of Spineway (ALSPW.PA) as of Oct 16, 2026 is -424,000.00 EUR. In the previous year, Capital Expenditures (CapEx) was -3.27 M EUR — a change of -87.05% (higher).

Capital Expenditures

-424,000.00EUR

YoY

-87.05%

Last updated:

Capital Expenditures (CapEx) of Spineway is 2025 -424,000.00 EUR. Capital Expenditures (CapEx) of Spineway was 2024 -3.27 M EUR. It decreases by -87.05% higher compared to the previous year.

The Spineway Capital Expenditures history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Capital Expenditures
Date
Capital Expenditures
Jan 1, 2018
-1.02 M EUR
Jan 1, 2019
-5.21 M EUR
Jan 1, 2020
-981,000.00 EUR
Jan 1, 2021
-1.09 M EUR
Jan 1, 2022
-12.27 M EUR
Jan 1, 2023
-1.46 M EUR
Jan 1, 2024
-3.27 M EUR
Jan 1, 2025
-424,000.00 EUR
The Spineway Capital Expenditures history
YEARCapital ExpendituresYoY
-424,000.00EUR-87.05%
-3.27 MEUR+123.94%
-1.46 MEUR-88.09%
-12.27 MEUR+1,031.15%
-1.09 MEUR+10.60%
-981,000.00EUR-81.18%
-5.21 MEUR+411.08%
-1.02 MEUR+0.79%
-1.01 MEUR+31.77%
-768,000.00EUR+16.36%
-660,000.00EUR-23.61%
-864,000.00EUR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Spineway Stock analysis

What does Spineway do? Spineway SA, listed on the Paris Stock Exchange under the ticker ALSPW.PA, is a healthcare company based in Ecully, France. The company, which went public on February 8, 2013, focuses on the design, production, and sale of spinal column implants and surgical instruments. Spineway employs 35 full-time staff and operates within the healthcare sector, specifically in the health care industry. The company's product portfolio includes spinal systems, cervical and lumbar cages, cervical plates, and bone substitutes. Spineway SA is headquartered in the Auvergne-Rhône-Alpes region, reflecting its local presence in a key French economic area. The company's website is www.spineway.com, providing access to further information about its operations and offerings. Spineway SA has not reported any acquisitions, specific founding year, or additional details beyond its current operational scope and employee count. The company's activities are centered on medical devices for spinal care, targeting healthcare providers and surgical professionals. Spineway is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Spineway stock

Capital Expenditures (CapEx) of Spineway is -424,000.00 EUR in 2025.

Capital Expenditures (CapEx) of Spineway changed from -3.27 M EUR to -424,000.00 EUR, representing a -87.05% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Capital Expenditures (CapEx) Spineway since 2006 – with annual values, charts, and detailed analysis.

Capital expenditures represent investments in long-term assets such as property, equipment, and technology. CapEx is essential for maintaining and growing the business.

Capital Expenditures (CapEx)'s EUR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Capital Expenditures (CapEx)'s Spineway historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Spineway

All Key Metrics — Spineway